Form 4: Marimed CFO Mario Pinho Converts Restricted Stock Units and Manages Tax Obligations

Marimed Inc.'s Chief Financial Officer, Mario Pinho, converted 100,020 Restricted Stock Units into common stock and had 34,657 shares withheld for tax obligations on July 15, 2025.

Summary

• Mario Pinho, Chief Financial Officer of Marimed Inc., acquired 100,020 shares of common stock on July 15, 2025, through the conversion of Restricted Stock Units (RSUs).
• Following the RSU conversion, 34,657 shares of common stock were disposed of at a price of $0.0969 per share to satisfy tax withholding obligations.
• After these transactions, Mario Pinho beneficially owns 145,884 shares of common stock.
• An additional 199,980 Restricted Stock Units remain, with 49,995 units scheduled to vest every six months through July 15, 2027.

Sentiment

Score: 5

Explanation: The filing is a routine Form 4 reporting the vesting and conversion of equity compensation, along with associated tax withholding. It does not contain information that would significantly alter the company's outlook or financial health, thus indicating a neutral sentiment.

Positives

• Conversion of Restricted Stock Units indicates the vesting of equity compensation for the Chief Financial Officer, aligning management's interests with shareholders.

Negatives

• A portion of the vested shares (34,657) was sold to cover tax liabilities, which is a common practice but reduces the direct shareholding.

Future Outlook

Remaining Restricted Stock Units (RSUs) totaling 199,980 are scheduled to vest in increments of 49,995 every six months through July 15, 2027, indicating future equity compensation for the Chief Financial Officer.

Industry Context

This filing is a routine insider transaction report (Form 4) and does not provide broader industry context or trends.

Related Party Transactions

• The reported transactions involve the conversion of Restricted Stock Units (RSUs) and the withholding of shares for tax obligations, which are standard equity compensation mechanisms between the company and its Chief Financial Officer.

Stakeholder Impact

• Shareholders: The conversion of RSUs into common stock increases the number of outstanding shares, potentially leading to minor dilution, but also aligns management incentives with shareholder value. The sale of shares for tax purposes is a common practice and does not necessarily indicate a lack of confidence.
• Employees: The vesting of RSUs demonstrates the company's commitment to its equity compensation plans for key personnel.

Next Steps

• Remaining 199,980 Restricted Stock Units will vest in increments of 49,995 every six months.
• The final vesting of remaining RSUs is scheduled for July 15, 2027.

Key Dates

Recommendation

Keywords

Marimed Inc., MRMD, Form 4, Insider Transaction, Restricted Stock Units, RSU Conversion, Equity Compensation, Chief Financial Officer, Mario Pinho, Stock Vesting, Tax Withholding